novo semaglutide alzheimer's 📢 BREAKING: New Trial Results Are In… But The Headlines Are Wrong Yesterday, Nordisk released results from its big phase 3 Evoke and Evoke+ trials testing oral (a GLP-1 📢 BREAKING: New Alzheimer's Trial

Living with type 2 diabetes or facing challenges with weight management brings daily demandsand finding the right medication, at the right price, can feel o...

PlexusDx explains the mechanisms behind treatment-related tiredness and evidence-based strategies to regain your energy

Discover trusted providers, learn about the benefits of semaglutide for weight loss, and start your journey to better health today.

GLP-1 weight loss plans from $86/month

Compared to baseline, DIO mice assumed phylogenetically similar gut bacterial compositional changes following liraglutide and GUB09-145 treatment, characterized by discrete shifts in low-abundant species and related bacterial metabolic pathways

The fusion has been engineered to deliver sustained peptide activity in vivo in combination with reduced potency, to manage GLP-1 driven adverse effects at high dose, and a favourable manufacturability profile